News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–18
Matches
18
Sources here
7
Companies here
1
Search results Stored financial headlines

Active search

18 matching headlines

Ticker or company: MDAIMain company stories
Clear
Latest

MarketBeat Analyst action

Spectral AI (NASDAQ:MDAI) Rating Increased to Hold at Wall Street Zen

Wall Street Zen has upgraded Spectral AI (NASDAQ:MDAI) from a "sell" to a "hold" rating, contributing to the stock's overall "Moderate Buy" consensus among analysts with an average price target of $4.00. Despite the company reporting a slightly better-than-expected quarterly loss per share, its revenue fell short of consensus estimates. Institutional investors hold a significant 67.08% stake in …

Spectral AI (MDAI): LMR funds report 6.2% beneficial stake via warrants

LMR-affiliated investment entities have reported a 6.2% beneficial ownership stake in Spectral AI, Inc. (MDAI) as of June 30, 2026. This ownership is primarily through warrants exercisable for 2,106,358 shares of Common Stock, with LMR Master Fund and LMR CCSA Master Fund each holding …

MDAI main company
Sharemaestro market context Price below Trend Line 52 weeks -19.6% MDAI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Spectral AI (NASDAQ:MDAI) Announces Quarterly Earnings Results, Beats Expectations By $0.01 EPS

Spectral AI (NASDAQ:MDAI) announced quarterly earnings, reporting a loss of $0.13 per share, beating the consensus estimate by $0.01. Despite revenue of $3.52 million falling short of analysts' forecasts, the company received FDA clearance for its DeepView burn-assessment system and reiterated its full-year revenue …

MDAI main company
Sharemaestro market context Price below Trend Line 52 weeks -19.6% MDAI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Spectral AI (NASDAQ: MDAI) wins FDA De Novo nod but faces revenue drop

Spectral AI reported a significant revenue drop in Q2 2026 and the first half of 2026, primarily due to reduced BARDA contract reimbursements as it shifts from government-funded development to commercialization. Despite this, the company received FDA De Novo classification for its DeepView System, …

MDAI main company
Sharemaestro market context Price below Trend Line 52 weeks -19.6% MDAI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Spectral AI (MDAI) to Release Quarterly Earnings on Tuesday

Spectral AI (NASDAQ:MDAI) is scheduled to release its Q2 2026 earnings after market close on Tuesday, August 11th. Analysts anticipate a loss of $0.14 per share and revenue of $4.17 million. The company's stock recently traded at $1.65, significantly below its 52-week high, yet …

MDAI main company
Sharemaestro market context Price below Trend Line 52 weeks -19.6% MDAI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Northland assumes Spectral AI stock coverage with outperform rating By Investing.com

Northland has initiated coverage on Spectral AI Inc. (NASDAQ:MDAI) with an Outperform rating and a $4.00 price target, seeing significant upside from the current trading price of $1.67. This positive outlook follows Spectral AI's recent FDA De Novo clearance for its DeepView System, which …

MDAI main company
Sharemaestro market context Price below Trend Line 52 weeks -19.6% MDAI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context